257 related articles for article (PubMed ID: 15577074)
1. [Role of aggrecanase and MMP in cartilage degradation].
Ishiguro N; Kojima T
Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
[TBL] [Abstract][Full Text] [Related]
2. An aggrecanase and osteoarthritis.
Karsenty G
N Engl J Med; 2005 Aug; 353(5):522-3. PubMed ID: 16079379
[No Abstract] [Full Text] [Related]
3. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
4. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Pattoli MA; MacMaster JF; Gregor KR; Burke JR
J Pharmacol Exp Ther; 2005 Oct; 315(1):382-8. PubMed ID: 16009742
[TBL] [Abstract][Full Text] [Related]
5. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
[TBL] [Abstract][Full Text] [Related]
7. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
Roughley PJ; Barnett J; Zuo F; Mort JS
Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
[TBL] [Abstract][Full Text] [Related]
8. The cleavage of biglycan by aggrecanases.
Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
[TBL] [Abstract][Full Text] [Related]
10. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
11. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.
Clements KM; Price JS; Chambers MG; Visco DM; Poole AR; Mason RM
Arthritis Rheum; 2003 Dec; 48(12):3452-63. PubMed ID: 14673996
[TBL] [Abstract][Full Text] [Related]
12. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
[TBL] [Abstract][Full Text] [Related]
13. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
Stanton H; Ung L; Fosang AJ
Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
[TBL] [Abstract][Full Text] [Related]
14. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
[TBL] [Abstract][Full Text] [Related]
15. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
16. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
17. Characterization of metalloprotease cleavage products of human articular cartilage.
Zhen EY; Brittain IJ; Laska DA; Mitchell PG; Sumer EU; Karsdal MA; Duffin KL
Arthritis Rheum; 2008 Aug; 58(8):2420-31. PubMed ID: 18668564
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
[TBL] [Abstract][Full Text] [Related]
19. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
20. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]